Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern.

Rao A, Bassit L, Lin J, Verma K, Bowers HB, Pachura K, Greenleaf M, Sullivan J, Lai E, Creager RS, Pribyl T, Blackwood J, Piantadosi AL, Schinazi R, Martin GS, Lam WA.

Open source

DOI
10.1016/j.isci.2022.103968
Published
2022-02-22
Container
iScience
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.isci.2022.103968,
  title = {Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern.},
  author = {Rao A and  Bassit L and  Lin J and  Verma K and  Bowers HB and  Pachura K and  Greenleaf M and  Sullivan J and  Lai E and  Creager RS and  Pribyl T and  Blackwood J and  Piantadosi AL and  Schinazi R and  Martin GS and  Lam WA.},
  year = {2022},
  journal = {iScience},
  doi = {10.1016/j.isci.2022.103968},
  url = {https://doi.org/10.1016/j.isci.2022.103968}
}

RIS

TY  - JOUR
TI  - Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern.
AU  - Rao A
AU  -  Bassit L
AU  -  Lin J
AU  -  Verma K
AU  -  Bowers HB
AU  -  Pachura K
AU  -  Greenleaf M
AU  -  Sullivan J
AU  -  Lai E
AU  -  Creager RS
AU  -  Pribyl T
AU  -  Blackwood J
AU  -  Piantadosi AL
AU  -  Schinazi R
AU  -  Martin GS
AU  -  Lam WA.
PY  - 2022
JO  - iScience
DO  - 10.1016/j.isci.2022.103968
UR  - https://doi.org/10.1016/j.isci.2022.103968
ER  - 

APA

A, R., L, B., J, L., K, V., HB, B., K, P., M, G., J, S., E, L., RS, C., T, P., J, B., AL, P., R, S., GS, M., & WA., L. (2022). Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern.. iScience. https://doi.org/10.1016/j.isci.2022.103968

Source records